Emil Kakkis

(Dr. Emil Kakkis M.D. Ph.D.)

Currently holds a position at Ultragenyx Pharmaceutical Inc

Positions

Position Company Period
President, Chief Executive Officer, Director Ultragenyx Pharmaceutical Inc None -
Emil Kakkis's trades of Ultragenyx Pharmaceutical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-04 2025-03-03
S Sale
73,434 -10.3%
42.10
USD 3,091,571 		73,434 -10.3% 42.10 USD 3,091,571
2025-03-04 2025-02-28
S Sale
25,000 -1.1%
42.48
USD 1,062,000 		25,000 -1.1% 42.48 USD 1,062,000
2024-12-31 2024-12-30
S Sale
11,727 -0.5%
42.23
USD 495,231 		11,727 -0.5% 42.23 USD 495,231
2024-12-11 2024-12-10
S Sale
8,273 -0.4%
50.00
USD 413,650 		8,273 -0.4% 50.00 USD 413,650
2024-09-05 2024-09-03
S Sale
20,000 -0.9%
55.85
USD 1,117,000 		20,000 -0.9% 55.85 USD 1,117,000
2024-08-07 2024-08-06
S Sale
20,000 -0.9%
50.17
USD 1,003,400 		20,000 -0.9% 50.17 USD 1,003,400
2024-02-08 2024-02-07
PS Planned sale
30,000 -5.3%
45.00
USD 1,350,000 		30,000 -5.3% 45.00 USD 1,350,000
2024-01-02 2023-12-29
PS Planned sale
30,000 -5.0%
47.87
USD 1,436,100 		30,000 -5.0% 47.87 USD 1,436,100
2023-10-23 2023-10-19
PS Planned sale
47,853 -7.4%
33.52
USD 1,604,033 		47,853 -7.4% 33.52 USD 1,604,033
2023-01-03 2022-12-30
PS Planned sale
19,582 -3.5%
45.57
USD 892,352 		19,582 -3.5% 45.57 USD 892,352
2021-03-03 2021-03-01
PS Planned sale
30,000 -1.3%
141.80
USD 4,254,000 		30,000 -1.3% 141.80 USD 4,254,000
2021-01-05 2021-01-04
PS Planned sale
30,000 -1.3%
136.90
USD 4,107,000 		30,000 -1.3% 136.90 USD 4,107,000
2020-11-04 2020-11-02
PS Planned sale
30,000 -1.3%
96.82
USD 2,904,600 		30,000 -1.3% 96.82 USD 2,904,600
2020-09-02 2020-09-01
PS Planned sale
30,000 -1.2%
82.63
USD 2,478,900 		30,000 -1.2% 82.63 USD 2,478,900
2020-07-15 2020-07-13
PS Planned sale
40,000 -1.6%
85.35
USD 3,414,000 		40,000 -1.6% 85.35 USD 3,414,000
2019-09-11 2019-09-11
B Purchase
5,000 +1.1%
43.63
USD 218,150 		5,000 +1.1% 43.63 USD 218,150
2016-10-18 2016-10-14
PS Planned sale
6,515 -1.3%
61.97
USD 403,735 		6,515 -1.3% 61.97 USD 403,735
2016-07-19 2016-07-15
PS Planned sale
13,550 -2.6%
50.61
USD 685,766 		13,550 -2.6% 50.61 USD 685,766
2016-01-04 2015-12-31
PS Planned sale
605 -0.1%
114.61
USD 69,339 		605 -0.1% 114.61 USD 69,339
2016-01-04 2015-12-31
PS Planned sale
2,702 -0.5%
113.83
USD 307,569 		2,702 -0.5% 113.83 USD 307,569
2016-01-04 2015-12-31
PS Planned sale
2,191 -0.4%
112.91
USD 247,386 		2,191 -0.4% 112.91 USD 247,386
2016-01-04 2015-12-30
PS Planned sale
2,600 -0.4%
116.31
USD 302,406 		2,600 -0.4% 116.31 USD 302,406
2016-01-04 2015-12-30
PS Planned sale
5,465 -0.9%
114.61
USD 626,344 		5,465 -0.9% 114.61 USD 626,344
2016-01-04 2015-12-30
PS Planned sale
2,837 -0.5%
113.30
USD 321,432 		2,837 -0.5% 113.30 USD 321,432
2004-05-07 2004-05-06
B Purchase
5,000 +23.7%
6.48
USD 32,400 		5,000 +23.7% 6.48 USD 32,400
2004-05-07 2004-05-06
B Purchase
10,000 +90.0%
6.50
USD 65,000 		10,000 +90.0% 6.50 USD 65,000
// ... existing code ... // ... rest of the file ...